1995.-Anterior latissimus dorsi (ALD) muscles of 3-wk-old male chickens were injected with plasmids containing various lengths of the chicken skeletal cx-actin promoter (ranging from -2,090 to -77 relative to the transcription start site) driving luciferase. Hypertrophy of the left ALD muscle was induced by attaching a weight (11% of body wt) to the left wing of each chicken, with the unweighted contralateral wing serving the control. Six days of stretch overload significantly increased muscle mass 110%. Luciferase activity from the -2,090 actin-luciferase chimeric gene increased 127% compared with the contralateral control ALD muscle. Luciferase activities driven by the -424, -202, and -99 actin promoters were 179, 134, and 378% higher, respectively, in the stretched ALD muscle than in the contralateral control ALD muscle. Luciferase activity from the -77 deletion construct was not different between stretched and control muscles. These data indicate that the gene region responding to stretch is downstream of -99 and imply, but do not conclusively prove, that the region between -99 and -77, which contains serum response element 1, contributes to the stretch-induced increase in skeletal at-actin promoter activity in the ALD muscle. muscle; exercise; contractile protein; gene ENLARGEMENT of skeletal muscle occurs in response to overload, but little is known about which regulatory sequences of genes are activated to cause the increased accumulation of contractile tissue in living animals (6). Stretch overloading of the chicken anterior latissimus dorsi (ALD) muscle results in an 80% increase in protein content after 7 days of chronic stretch overload (16) and a 140-225% increase in the synthesis rate of actin protein at l-3 days of stretch overload (11). These data demonstrate that a-actin gene expression is increased during stretch-induced hypertrophy. Regulation of expression level, tissue specificity, and development are mediated by sequences within the region -2,000 to +239 of the transcription start site of the human skeletal a-actin gene in transgenic mice (7). The region -153 to -87 base pairs (bp) from the transcription start site of the human skeletal oc-actin promoter is both sufficient and necessary for musclespecific expression and developmental regulation during myogenesis (7). Chicken skeletal ar-actin gene regulation in primary myogenic culture has been well described (4, 19) . The first -200 bp 5' of the chicken skeletal oc-actin transcription start site give tissue-specific regulation of the gene in myogenic cell culture (4) and transgenic mice (28). This region contains consensus cis-acting DNA regulatory sequences that include three serum response elements (SRE)/CArG/CBAR, E box, transcription enhancing factor l/M-CAT binding site, two Spl sites, and TATA box (4). These cis-acting elements and their orientation in the proximal promoter region of the skeletal ar-actin gene have been strongly conserved during evolution in chickens, mice, rats, and humans (23, 26). The chicken and rat skeletal ar-actin genes contain four highly conserved regions found between -80 and -230 bp from the transcription start site (25). These include regions corresponding to cis-acting DNA regulatory elements SREl and SRE2 and an E box, which binds the MyoD family of myogenic proteins. A consensus transcription-enhancing factor 1 binding site (-66 to -60) is also conserved between the rat and chicken skeletal a-actin promoters (25). Despite this large amount of information, less is known about the activity of the chicken skeletal a-actin promoter during skeletal muscle hypertrophy in living animals. Plasmid DNA injected into skeletal muscle has been shown to be taken up by muscle fibers, to be stably expressed, to produce proteins for antibody production by the injected muscle, and to be useful for promoter analysis (1, 8, 20, 29, 36, 37, 39-41). We wanted to test whether direct plasmid injection methodology would allow the study of skeletal ar-actin gene regulation using an established animal model to elicit hypertrophy. Deletions of the 5'-flanking region of the chicken skeletal ar-actin gene driving expression of the firefly luciferase coding region were injected into stretch-overloaded and contralateral control ALD muscles of rapidly growing chickens. The purposes of the present study were to determine whether chimeric gene expression from the -2,090-bp ar-actin promoter is increased during hypertrophy of the ALD and, if there is an increase in expression, to define a region within -2,090 bp of the 5'-flanking region of the skeletal cx-actin promoter that may have elements responding to stretch overload.
MATERIALS AND METHODS
Animal care and preparation. One-day-old roosters (White Leghorn males, Ideal-286, Ideal Hatcheries, Cameron, TX) were received and housed at the animal care facilities, University of Texas Health Science Center at Houston. The chickens were provided chicken laboratory diet and water ad libitum in a chicken brooder with a 12:12-h light-dark cycle. At -3 wk of age the chickens were housed two per cage for the duration of the study. The chickens used in the study were between 3 and 5 wk of age (200-400 g (Fig. 1) . A plasmid containing the long terminal repeat of the Rous sarcoma virus (RSV) directing the cDNA for chloramphenicol acetyltransferase (CAT) was also used in the study. The plasmid pRSVCAT contains RSVCAT in vector pBR322, a low-copy-number vector. The plasmid yield was improved by subcloning the RSV promoter and CAT coding region from the pRSVCAT plasmid into the high-copy-number vector pUC18. pOCAT was injected to obtain promoterless CAT expression. PLasmid purification.
Plasmid DNA was transformed into XLl-Blue bacteria (Stratagene). The bacteria were then grown for 15 h in LB medium with moderate shaking at 37°C. Plasmids were isolated and purified using alkaline lysis with differential polyethylene glycol precipitation and subsequent phenol extractions (31). DNA concentration and purity was determined by ultraviolet spectrophotometry using AzGO and A260-to-A280 ratio. Plasmid preparations were then subjected to analysis by restriction endonuclease digestion and agarose gel electrophoresis to demonstrate the DNA was correct and free from contamination. Plasmid DNA was stored in sterile dHzO at -80°C until the time of use. Directplasmid injection. The right and left ALD muscles of 3-wk-old chickens were injected with plasmid DNA using methodology described by Wolff et al. (41). Chickens were anesthetized using a ketamine-xylazine-acepromazine (25, 1, and 1.5 mg/kg, respectively) cocktail. A single incision was made along the spine adjacent to the right and left ALD muscles. The ALD muscles were visualized and preinjected with 25 ~1 of sterile 25% sucrose (8) at the midbelly of the muscle with a 27-gauge needle. Approximately 20 min later 50 pg of the appropriate actin-luciferase plasmid and 50 kg of RSVCAT plasmid were injected together in a final volume of 20 ~1. A single-track injection of plasmid DNA at the midbelly of the muscle was performed over a 30-s time period using a 25-~1 Hamilton syringe with a sterile 27-gauge needle. The -2,090 actin-luciferase DNA (65 pg) was injected with 50 pg of RSVCAT to make the DNA injected equal in molar amount to the smaller length promoter constructs. Interestingly, similar methodology used to inject plasmid DNA into the patagialis muscle of the chicken did not illicit consistent expression.
Wing weighting. Two days after having been injected with the appropriate plasmid DNA, the chickens had a weight corresponding to 11% of their body weight attached to the left wing. The contralateral wing was not weighted and served as the control (2). After 6 days of wing weighting the ALD muscles were removed, frozen in liquid N2, and stored at -80°C.
Assays for Zuciferase and CAT activity. ALD muscles were homogenized in l-3 ml of homogenate buffer [25 mM tris(hydroxymethyl)aminomethane (Tris), 5.7 mM trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacteic acid, 10% glycerol, 2 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM bezamidine, 0.01 mg/ml leupeptin, and 0.01 mg/ml pepstatin] using a Polytron homogenizer (Kinematica, Switzerland) at 60% of maximum setting (3 x 10 s) and then centrifuged (10,000 g, 10 min, 4°C). The supernatant containing the crude protein extract was analyzed for luciferase and CAT activity. Luciferase activity was determined using 20 ~1 of muscle extract incubated for 70 s with 100 ~1 of luciferase reagent produced by mixing 20 mM tricine (pH 7.8), 1.07 mM (MgCO&Mg(OH)2*5H20, 2.67 mM MgS04, 0.1 mM EDTA, 0.53 mM ATP, 0.27 mM coenzyme A, 33.3 mM DTT, and 0.47 PM luciferin.
Light The portions of the plates containing the acetylated and unacetylated chloramphenicol for each sample were excised and quantified by scintillation counting. The percentage conversion of acetylated chloramphenicol was presented as the percentage conversion per minute. The CAT activity was corrected for the volume of muscle homogenate to give percentage conversion per minute per muscle. This value was then used to correct TRLU activity in TRLUICAT for each muscle (37). Only birds with CAT activities >0.25 %conversion l min-l *muscle-l in both the control and the stretched ALD were utilized in the study (15). Uninjected muscles were analyzed each day of assays, and they served as the background, which was subtracted from samples run on that day.
For each muscle, the ratio of the two reporter genes was calculated: luciferase activity/CAT activity = TRLU/fraction of chloramphenicol that is acetylated. Values of luciferase/ CAT for each muscle are used for calculation of means 2 SE in each treatment group.
MyobZast cuZture and transfection. Primary embryonic chicken myoblast cultures were established from breast tissue of 1 l-day-old chicken embryos as described previously (13). Myoblasts were plated at a density of 8 x lo5 cells into collagen-coated 60-mm plastic Petri dishes in minimum essential medium supplemented with 10% horse serum, 5% chicken embryo extract, and 50 kg/ml gentamicin sulfate and maintained at 37°C and 5% CO2 in a humidified incubator. Myoblasts were transfected 24 h postplating with 5 pg/plate of the same chicken skeletal cx-actin promoter constructs that had been injected into the ALD muscle and 2 pg/plate pCMVGAL (Clonetech, Palo Alto, CA) using DEAE-dextran essentially as described previously (22). Briefly, myoblasts were washed three times with Hanks' balanced salt solution, 3 ml/plate minimum essential medium containing specified DNA plasmid constructions and 150 pg/ml DEAE-dextran (Sigma, St. Louis, MO) were then added, and myoblasts were incubated for 3 h at 37°C in a humidified incubator. After 3 h, media were aspirated and myoblasts were exposed to a 10% dimethyl sulfoxide (DMSO) shock (90% minimum essential medium and 10% DMSO) for 90 s. Myoblasts were then washed three times with Hanks' balanced salt solution, fed with 3 ml/plate minimum essential medium supplemented with 10% horse serum, 2% chicken embryo extract, and 50 kg/ml gentamicin sulfate, and maintained at 37°C and 5% CO2 in a humidified incubator. After 45 h (i.e., N 72 h postplating), myoblasts/myotubes were washed three times with phosphate-buffered saline and then lysed in 200 kl/plate 0.25 M Tris Cl (pH 7.8) and 0.1% Triton X-100. Myotube lysates were transferred to 1.5-ml microcentrifuge tubes and then clarified by centrifugation at 12,000 g for 5 min at 4°C. The supernatants were stored at -70°C for subsequent luciferase and P-galactosidase (3 1) assays. RNA isolation.
Stretched and control ALD muscles were divided into two pieces, a 20-to 40-mg piece of muscle was saved at -80°C for total RNA determination (see below), and the remainder was powdered in liquid N2 for cx-actin mRNA determination.
RNA was extracted using the RNAzol B method (Biotecx Laboratories, Houston, TX). Briefly, muscle tissue was homogenized with RNAzol B and treated with chloroform A chicken skeletal <x-actin cDNA probe was prepared by random priming (9) of a unique 221-bp fragment of the chicken skeletal a-actin cDNA taken from the 3'-untranslated region (UTR) of the chicken a-actin gene. DNA template for labeling was prepared by polymerase chain reaction amplification of the unique 3'-UTR fragment from the clone (x-SK.22 described previously ( 13). The membrane containing the RNA was prehybridized with 12-ml hybridization buffer (QuickHyb, Stratagene) for 30 min at 68OC. An aliquot of cx-actin mRNA probe (3.7 x lo7 cpm; sp act log cpm/pg DNA) was mixed with the hybridization buffer and incubated for 2 h at 68°C. The membrane was washed two times with 2 x sodium chloride-sodium citrate (SSC)-0.1% sodium dodecyl sulfate (SDS) (2O"C, 15 min) and once with 0.1 x SSC-0.1% SDS (55"C, 30 min). The membrane was then visualized by autoradiography (-8O"C, 3 h), and the band corresponding to a-actin mRNA was then quantified by densitometry scanning (Bio Image, Millipore, Ann Arbor, MI) as the integrated optical density (IOD) and used to calculate IOD cx-actin mRNA per microgram of RNA. The quantity of cx-actin mRNA was normalized to ethidium bromide-stained 28s RNA, which was determined by image analysis (Bio Image) (5). TotaZ RNA determination.
Total RNA was quantified using the method of Fleck and Munro (10).
Statistics. The data are expressed as means * SE. A paired t-test was used to determine differences between the stretched and control ALD, and P < 0.05 was designated significant.
RESULTS
Body weight and ALD mass. The body weights of the chickens (n = 69) were 202.9 t 3.2 g at the time of injection (day O), 211.9 t 3.8 g at the time of wing weighting (day Z), and 283.5 t 5.8 g after 6 days of wing weighting (day 8). The wet weight of the stretchoverloaded ALD muscle (226.8 t 4.8 mg) was increased significantly (110%; n = 69, P = 0.0001) above the contralateral control ALD (107.9 t 2.7 mg) after 6 days of wing weighting.
Total RNA and cu-actin mRNA. Six days of wing weighting caused the total RNA per gram of wet weight to increase significantly (42%; n = 9, P = 0.003) in the stretched ALD muscle (3.00 t 0.09 mg RNA/g muscle) compared with the contralateral control (2.11 t 0.11 mg RNA/g muscle). Total RNA for the entire muscle in the stretch-overloaded ALD was 239% greater than in the contralateral control ALD (755.0 kg RNA/muscle vs. 223.5 pg RNA/muscle, respectively).
cx-Actin mRNA per microgram of RNA was decreased significantly (32%; n = 9, P = 0.01) in the stretchoverloaded ALD compared with the control muscle ( Table 1, Fig. 2) . Th is was due to the increase in total Fig. 2 ). *P < 0.05 from contralateral control.
RNA concentration. There was no significant difference (P = 0.27) between the control and stretch-overloaded ALD in the actin mRNA per gram of wet weight ( Table  1 ). The quantity of cY-actin mRNA in the whole ALD muscle was increased significantly (98%, P = 0.002) by stretch overload above the contralateral control (Table  1) . Plasmid injections had no effect on quantity of actin mRNA in the stretched or control ALD muscles (data not shown).
Dose-response curve for chimeric gene expression from -424-bp a-a&in promoter. A dose-response curve was done with varying quantities (25-100 kg) of the -424-bp a-actin promoter directing the cDNA for luciferase coinjected with 50 Fg of RSVCAT plasmid (Fig. 3) . A 50-kg dosage of the -424 actin/luciferase construct was in the linear range of chimeric gene expression when examined for total luciferase activity and luciferase activity corrected for CAT activity.
Promoter-less expression. Luciferase activity determined from ALD muscles injected with 50 kg of pGL2 basic was 1,537 + 787 in untreated wings and 1,730 + 783 in stretched wmgs (n = 13; Table 2 ). These activities are 10 and 16% of those found in control and stretch muscles, respectively, receiving 50 p,g of -77 actin directing luciferase. CAT activities were not detectable in muscles injected with 50 kg of a promoterless CAT construct (pOCAT).
Chicken a-a&in promoter activity. The longest length of the chicken o-actin promoter in this experiment was -2,090 bp from the a-actin transcription start site. The left and right ALD muscles were injected with 65 kg of -2,090 actin-luciferase plasmid and 50 pg of RSVCAT, and the left wing weighted 2 days postinjection. Activity from the -2,090-bp promoter, corrected for RSVCAT expression, was significantly increased by 127% (P = 0.05; n = 17) in the hypertrophied ALD compared with the contralateral control during 6 days of stretch overload (Fig 4) . This increase in luciferase/CAT expression was due to a greater increase in TRLU than the increase in CAT activity in the hypertrophied muscle (see Table 2 ).
Deletion analysis was performed on the a-actin promoter to determine the region responsible for the increase in chimeric gene expression during stretchinduced hypertrophy.
Four deletions of the -2,090 bp promotor were used (Fig. 1) . The appropriate deletion construct (50 kg) was coinjected with 50 p,g of RSVCAT into the right and left ALD. o-Actin promoter activity in the control ALD muscle increased as the a-actin promoter length increased, peaking with the -424-bp promoter and decreasing at -2,090 bp (Fig. 4) . a-Actin chimeric gene expression, corrected for RSV-CAT expression, was elevated significantly in the hypertrophied ALD compared with the contralateral control in birds injected with plasmid DNA containing -424 (179%, P = 0.004), -202 (134%, P = 0.0184), and -99 (378%, P = 0.0007) promoters (Fig. 4) . The corrected chimeric gene expression from the -77-bp promoter was not altered significantly (P = 0.2891) in the hypertrophied ALD (luciferase/CAT = 74,310) compared with the contralateral control (luciferase/CAT = 495,610; Fig. 4 ). These data demonstrate that the 22-bp region located from -77 to -99 bp from the a-actin transcription start site could contain a regulatory element(s) responsible for the increase in chimeric gene expression during stretch overload-induced hypertrophy.
Expression of skeletal a-actin promoter in cultured muscle cells. Progressive deletions in the first 200 bp (-77, -99, and -202) of the cu-actin promoter produced a pattern of activity in control ALD (Fig. 4) and cultured chicken muscle cells (Fig. 5) expression pattern previously reported in cultured chicken myocytes (4). However, it has previously been reported that the -2,000, -422, and -200 length chicken skeletal cx-actin promoter activities were not different when driving the reporter gene CAT (4). We have found that the activities of these promoters driving the reporter gene luciferase in control muscles of the live animal and in cultured myocytes are different, with the -424 promoter expressing significantly higher than either the -202 or -2,090 cx-actin promoter constructs (Figs. 4 and 5) . W e speculate that either the shorter half-life of luciferase relative to CAT or the method of transfection could account for these differences (32).
DISCUSSION
Results of the current study suggest that a region which is within the first 99 bp of the chicken ar-actin promoter is required for the stretch-induced increase in the activity of this promoter. Furthermore, these data suggest that the region between -77 and -99 may contain DNA regulatory elements necessary for this stretch-induced increase in expression. This region corresponds to the location of a cis-acting DNA regulatory element called SREl, consisting of the sequence 5'-CCAAATATGGC-3' from -81 to -91 bp. SRE 1 matches the consensus sequence reported for the SRE (5'-CC(A/ T),GG-3') (34) and is the most proximal of three serum response elements found in the chicken skeletal a-actin promoter (5).
The consensus motif for the SRE has been found in the 5'-flanking regions of many growth factor-inducible genes (34) and muscle-specific genes (19, 21, 27). However, the SRE was first described in the regulation of the c-fos protooncogene (34). Increased c-fos transcription in cultured cells after serum induction was found to be mediated through the SRE in the c-fos promoter (33). Subsequently, the SRE located in the c-fos promoter has been shown to mediate increases in chimeric gene expression during the stretching of cardiac myocytes in culture (30) and in the pressure-overloaded heart using plasmid injection methodology (3). These observations could explain why stretch could activate SREl of the chicken skeletal oc-actin promoter REFERENCES but not further activate actin promoter activity through SRE2 and SRE3 in the same promoter.
The SREl in the actin promoter and the SRE in the c-fos promoter are not equivalent. The skeletal ar-actin promoter is muscle specific; when the skeletal muscle SREl is replaced by the c-fos SRE, expression occurs in both muscle and nonmuscle cells (38). The c-fos SRE is associated with an ets domain, binding p6ZTcF. A point mutation at the p62 TCF binding site of the SRE in the c-fos promoter abolishes activation of this promoter due to acute pressure overload of the heart. This demonstrates a role for p6ZTCF in the signaling of stretchinduced increases in expression from the c-fos promoter (3). SREl of th e c ic h' k en skeletal actin promoter (18) and several other SREs (35) do not contain a discernible ets motif, and this has been interpreted to mean that p6ZTCF binding may not be common to all SREs (35). Because of these contextual differences surrounding SREs (14,35), it is not certain that results from the c-fos SRE in heart muscle can be applied to SREl of the chicken skeletal ar-actin gene.
Our current data suggest that the chicken skeletal cx-actin gene also contains an important, but distinct from the human gene, regulatory element(s) upstream of the -202-bp promoter (Figs. 4 and 5) . Research with the human skeletal ar-actin promoter has found distal enhancers -1,282 to -708 bp from the transcription start site that increase the expression of the gene lo-fold (24). It is possible that an additional activator elements exist from -202 to -424 and/or that repressor elements are present from -424 to -2,090 in the chicken skeletal ar-actin promoter.
In summary, our results demonstrate that direct plasmid injection techno logy can be combined with promoter ) deletion analysis during stretch-induced hyper---trophy of skeletal muscle in the living animal to determine promoter activity. These data show that chimeric gene expression from -2,090-bp chicken ar-actin promoter is increased during hypertrophy of the ALD muscle induced by chronic stretch overload. These data indicate that the gene region responding to stretch is downstream of -99 and imply, but do not conclusively prove, that the region between -99 and -77 contributes to the stretch-induced increase in the skeletal ar-actin promoter in the ALD muscle. Further experime nts will
